PHARMASEAL Revenue and Competitors
Estimated Revenue & Valuation
- PHARMASEAL's estimated annual revenue is currently $2.4M per year.
- PHARMASEAL's estimated revenue per employee is $201,000
Employee Data
- PHARMASEAL has 12 Employees.
- PHARMASEAL grew their employee count by -8% last year.
PHARMASEAL's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Director Quality and Operations | Reveal Email/Phone |
3 | Chief Product Officer | Reveal Email/Phone |
4 | Software Engineer | Reveal Email/Phone |
5 | Software Engineer | Reveal Email/Phone |
6 | Software Engineer | Reveal Email/Phone |
PHARMASEAL Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is PHARMASEAL?
PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision to create smarter technologies and innovative products for the improvement of human health. The company's first product Engility CTMS simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility CTMS utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.
keywords:N/AN/A
Total Funding
12
Number of Employees
$2.4M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 12 | 0% | N/A |
#2 | $1.5M | 12 | 0% | N/A |
#3 | $1M | 12 | N/A | N/A |
#4 | $1.6M | 13 | -24% | N/A |
#5 | $3M | 15 | -17% | N/A |